Autoimmune Encephalitis After Treatment of Hodgkin's Lymphoma with the Immune Checkpoint Inhibitor Nivolumab

In recent years, by the usage of new immune therapeutic agents for cancer treatment, the neurologic adverse events began to be seen more frequently. Nivolumab, one of the immune checkpoint inhibitor, is a human IgG4 antibody that blocks programmed cell death protein 1 and is approved against metasta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Noro-Psikiyatri Arsivi 2021-06, Vol.58 (2), p.163-165
Hauptverfasser:	Nalbantoglu, Mecbure, Altunrende, Burcu, Tunçer, Özlem Güngör, Akman, Gülsen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Apoptosis Autoimmune diseases Cancer Cancer therapies Case Report Chemotherapy Complications and side effects Drug therapy Encephalitis Glucose Immunoglobulin G Immunotherapy Ipilimumab Kidney cancer Lung cancer Lymphoma Lymphomas Melanoma Metastasis Monoclonal antibodies Patients Proteins Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!